# Metabolomic Diagnostics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/metabolomic-diagnostics

- Industry: Healthcare IT
- Headquarters: Cork, Ireland
- Website: www.metabolomicdiagnostics.com/
- Total disclosed funding: $3.2M
- Latest round: Seed (Apr 6, 2018)
- Investors on record: 3

## About

Based in Cork, Ireland, and founded in 2011 by co-founders Louise Kenny, Charles Garvey, Diarmuid Cahalane, Robin Tuytten, Ph.D. (CEO), and Paul Hands, Metabolomic Diagnostics Ltd. operates as a provider of a diagnostic platform that develops biomarker-based tests for predicting and preventing complicated diseases to medical institutions and maternal health practitioners. In September 2024, Trinity Biotech, a portfolio company of DeltaPoint Capital Partners, acquired Metabolomic Diagnostics Ltd. for approximately USD 1.3 million.

The company provides a mass spectrometry-based diagnostic platform that offers advanced biomarker analysis to healthcare providers. The platform's services include diagnostic testing, data interpretation, and statistical analysis for reliable results. Moreover, the firm offers solutions such as preeclampsia screening and maternal health diagnostics, focusing on early detection of pregnancy-related risks. Additionally, Metabolomic Diagnostics Ltd. also provides predictive testing for complications so that healthcare professionals have access to critical information for improved patient care and outcomes.

## Funding rounds

- Seed, Apr 6, 2018, $1.3M — SOSV
- Seed, Feb 11, 2015, $0.8M — Enterprise Ireland, SOSV, Furthr
- Seed, Mar 12, 2014 — SOSV
- Seed, Dec 20, 2013, $1M — Enterprise Ireland, SOSV, Furthr

## Investors

- Enterprise Ireland (https://capitalatlas.ai/funds/enterprise-ireland) — Seed
- SOSV (https://capitalatlas.ai/funds/sosv) — Seed
- Furthr (https://capitalatlas.ai/funds/furthr) — Seed